Zileuton 600 mg 12HR Extended Release Oral Tablet
RxNorm 730834
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 730834 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: zileuton 600 mg 12HR Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
12 HR zileuton 600 mg Extended Release Oral Tablet
(Atom ID: 6348384)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely zileuton 600 mg/1 each prolonged-release oral tablet (clinical drug)
(Atom ID: 11440921)
SYPrescribable
Synonym (SY):
Zileuton 600 mg 12 HR Extended Release Oral Tablet
(Atom ID: 6354918)
PSNPrescribable
Prescribable Name (PSN):
Zileuton 600 mg 12HR Extended Release Oral Tablet
(Atom ID: 6368426)
PTPrescribable
Designated preferred name (PT):
Zileuton 600 mg prolonged-release oral tablet
(Atom ID: 11441652)
Patient Education
Zileuton
Zileuton is used to prevent wheezing, shortness of breath, coughing, and chest tightness due to asthma. Zileuton is not used to treat an asthma attack (sudden episode of shortness of breath, wheezing, and coughing) that has already started. Zileuton belongs to a class of medications called leukotriene synthesis inhibitors. It works by stopping the formation of certain natural substances that cause swelling, tightening, and mucus production in the airways.
[Learn More]
* Please review the disclaimer below.